Episode Summary
In this Verisian Community Podcast episode, we welcome Ritika Aggarwal from Novartis, who shares insights on the evolving landscape of statistical programming. Addressing challenges like data complexity and the rise of AI, Ritika frames these as opportunities for innovation. We touch on the industry's adaptation to the "new normal," the crucial role of continuous learning for programmers, and the importance of staying updated with changing clinical data standards. Ritika's experiences offer a deep dive into the dynamic field of statistical programming, highlighting the potential for professional growth and the overall advancement of the industry.
00:00 - Welcome
0:55 - Introduction to Ritika
2:08 - Why Statistical Programming
4:10 - Challenges in communicating studies to regulators
6:03 - How can organisations embrace new technologies
10:06 - What is the "New Normal"
13:36 - How to stay up to date with changing CDISC standards
17:23 - Participating in the community
20:16 - How is the industry tackling new challenges
22:57 - Application of Admiral in industry
26:20 - The rise of R in submissions
29:30 - Career advice for new programmers
32:20 - Final remarks
About The Verisian Community Podcast
The Verisian Community Podcast brings together experts in clinical trials to exchange innovative ideas and best practices central to clinical reporting, submission and review. Aligned with Verisian's mission to accelerate the evaluation and market launch of new medical treatments, each episode features expert insights, with guests ranging from statistical programmers to medical writers, to discuss the challenges and opportunities of the latest software and technology.
Resources
Learn more about us: https://www.verisian.com/
Join the Verisian Community: https://www.verisian.com/community
Follow us on LinkedIn: / verisian
Listen on:
Spotify: https://open.spotify.com/show/6EnSKNp...
Apple Podcasts: https://podcasts.apple.com/us/podcast...